Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jasper Therapeutics, Inc.(JSPR) | 1,471,904 | 1,433,828 | -38,076 | $32.55M | $26.97M | 29.28% | -$5.58M |
| Praxis Precision Medicines, Inc.(PRAX) | 350,666 | 350,666 | 0 | $14.50M | $20.18M | 21.90% | +$5.67M |
| Heron Therapeutics, Inc.(HRTX) | 6,986,744 | 6,986,744 | 0 | $24.45M | $13.90M | 15.09% | -$10.55M |
| Tourmaline Bio Inc | 319,080 | 331,190 | +12,110 | $4.10M | $8.51M | 9.24% | +$4.41M |
| Rezolute, Inc.(RZLT) | 800,000 | 800,000 | 0 | $3.44M | $3.88M | 4.21% | +$440.0K |
| Liquidia Corporation(LQDA) | 0 | 300,000 | +300,000 | $0 | $3.00M | 3.26% | +$3.00M |
| Context Therapeutics Inc.(CNTX) | 1,290,323 | 1,290,323 | 0 | $2.59M | $2.53M | 2.75% | -$58.1K |
| InspireMD, Inc.(NSPR) | 904,029 | 904,029 | 0 | $2.26M | $2.42M | 2.63% | +$167.0K |
| Scpharmaceuticals Inc | 0 | 517,668 | +517,668 | $0 | $2.36M | 2.56% | +$2.36M |
| TELA Bio, Inc.(TELA) | 746,087 | 747,410 | +1,323 | $3.51M | $1.89M | 2.05% | -$1.62M |
| Optinose Inc | 2,492,830 | 2,146,608 | -346,222 | $2.59M | $1.44M | 1.56% | -$1.15M |
| Zevra Therapeutics, Inc.(ZVRA) | 0 | 200,000 | +200,000 | $0 | $1.39M | 1.51% | +$1.39M |
| Protara Therapeutics, Inc.(TARA) | 480,000 | 574,000 | +94,000 | $998.4K | $1.05M | 1.14% | +$52.0K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 50,000 | +50,000 | $0 | $1.03M | 1.12% | +$1.03M |
| Skye Bioscience, Inc.(SKYE) | 422,142 | 211,071 | -211,071 | $3.38M | $825.3K | 0.90% | -$2.56M |
| Kiora Pharmaceuticals, Inc.(KPRX) | 122,223 | 122,223 | 0 | $513.3K | $447.3K | 0.49% | -$66.0K |
| Tenax Therapeutics, Inc.(TENX) | 0 | 83,333 | +83,333 | $0 | $288.3K | 0.31% | +$288.3K |
| Alimera Sciences Inc | 13,608,533 | 0 | -13,608,533 | $75.66M | $0 | — | -$75.66M |
| Aslan Pharmaceuticals LtdADS | 625,000 | 0 | -625,000 | $187.5K | $0 | — | -$187.5K |
| Elevation Oncology Inc | 597,299 | 0 | -597,299 | $1.61M | $0 | — | -$1.61M |
| Outlook Therapeutics, Inc.(OTLK) | 247,084 | 0 | -247,084 | $1.82M | $0 | — | -$1.82M |
| X4 Pharmaceuticals, Inc.(XFOR) | 659,020 | 0 | -659,020 | $382.2K | $0 | — | -$382.2K |